Method of regulating nitric oxide production or arthritis with soluble IL-17 receptor
US6083906A · kind A · utility
30Cited by
2References
8Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 26, 1997 |
| Grant date | Jul 4, 2000 |
| Priority date | — |
| Expiry date | Nov 26, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods for regulating levels of nitric oxide are disclosed. The methods utilize IL-17 receptors, which may be used in conjunction with inhibitor of IL-1 and/or TNF.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.